Macrophage activation syndrome:: characteristic findings on liver biopsy illustrating the key role of activated, IFN-γ-producing lymphocytes and IL-6- and TNF-α-producing macrophages

被引:222
作者
Billiau, AD
Roskams, T
Van Damme-Lombaerts, R
Matthys, P
Wouters, C
机构
[1] Univ Hosp Gasthuisberg, Dept Histopathol, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Lab Expt Transplantat, Louvain, Belgium
[3] Katholieke Univ Leuven, Rega Inst Med Res, Immunobiol Lab, Louvain, Belgium
关键词
D O I
10.1182/blood-2004-08-2997
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Macrophage activation syndrome (MAS) is a rare and potentially fatal disorder, thought to result from uncontrolled activation and proliferation of T cells and excessive activation of macrophages. The term MAS designates a clinicopathologic entity that occurs in different hemophagocytic syndromes (HSs). Primary hemophagocytic lymphohistiocytosis (HLH) is recognized to have an immunogenetic basis, but in the secondary HS (also referred to as secondary HLH), the cause is unknown. The pathogenesis of the accelerated disease phase typical of MAS remains incompletely understood. This report describes the immunohistochemical findings on liver tissues from 5 children, each of whom presented with MAS in the context of a different type of HS. The data provide direct evidence for the involvement of activated CD8(+) lymphocytes through the production of interferon-gamma and of macrophages through hemophagocytosis and production of interleukin 6 and tumor necrosis factor-alpha, and underscore the view that MAS in different HSs share a common effector pathway. (C) 2005 by The American Society of Hematology.
引用
收藏
页码:1648 / 1651
页数:4
相关论文
共 22 条
[1]   INVOLVEMENT OF INTERFERON-GAMMA AND MACROPHAGE-COLONY-STIMULATING FACTOR IN PATHOGENESIS OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADULTS [J].
AKASHI, K ;
HAYASHI, S ;
GONDO, H ;
MIZUNO, S ;
HARADA, M ;
TAMURA, K ;
YAMASAKI, K ;
SHIBUYA, T ;
UIKE, N ;
OKAMURA, T ;
MIYAMOTO, T ;
NIHO, Y .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (02) :243-250
[2]   Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies [J].
De Vos, R ;
Verslype, C ;
Depla, E ;
Fevery, J ;
Van Damme, B ;
Desmet, V ;
Roskams, T .
JOURNAL OF HEPATOLOGY, 2002, 37 (03) :370-379
[3]   Histopathology of the liver in histiocytosis syndromes [J].
Favara, BE .
PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1996, 16 (03) :413-433
[4]  
FAVARA BE, 1992, SEMIN DIAGN PATHOL, V9, P63
[5]  
Favara BE, 1997, MED PEDIATR ONCOL, V29, P157, DOI 10.1002/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO
[6]  
2-C
[7]   LYMPHOHISTIOCYTOSIS - A MULTI-FACTORIAL SYNDROME OF MACROPHAGIC ACTIVATION CLINICOPATHOLOGICAL STUDY OF 38 CASES [J].
GOLDBERG, J ;
NEZELOF, C .
HEMATOLOGICAL ONCOLOGY, 1986, 4 (04) :275-289
[8]   Natural killer cell dysfunction - A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? [J].
Grom, AA .
ARTHRITIS AND RHEUMATISM, 2004, 50 (03) :689-698
[9]   Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? [J].
Grom, AA .
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (05) :587-590
[10]   FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS MACROPHAGES SHOWING IMMUNOHISTOCHEMICAL PROPERTIES OF ACTIVATED MACROPHAGES AND T-ACCESSORY CELLS [J].
HANSMANN, ML ;
RONTOGIANNI, D ;
JANKASCHAUB, GE ;
WACKER, HH ;
HINKELDEY, K ;
RADZUN, HJ .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1989, 6 (03) :237-246